Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases

Eur Respir J. 2017 Feb 15;49(2):1601855. doi: 10.1183/13993003.01855-2016. Print 2017 Feb.

Jakko van Ingen^{1

2}, Dirk Wagner^{3

2}, Jack Gallagher⁴, Kozo Morimoto⁵, Christoph Lange^{6

7

8

9}, Charles S Haworth¹⁰, R Andres Floto¹⁰, Jennifer Adjemian^{11

12}, D Rebecca Prevots¹¹, David E Griffith¹³; NTM-NET

¹ Dept of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands jakko.vaningen@radboudumc.nl.
² Both authors contributed equally.
³ Division of Infectious Diseases, Dept of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
⁴ Clarity Pharma Research LLC, Spartanburg, SC, USA.
⁵ Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan.
⁶ Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
⁷ German Center for Infection Research (DZIF), Clinical Tuberculosis Unit, Borstel, Germany.
⁸ International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany.
⁹ Dept of Medicine, Karolinska Institute, Stockholm, Sweden.
¹⁰ Cambridge Centre for Lung Infection, Papworth Hospital and Dept of Medicine, University of Cambridge, Cambridge, UK.
¹¹ National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
¹² United States Public Health Service, Commissioned Corps, Rockville, MD, USA.
¹³ University of Texas Health Science Center, Tyler, TX, USA.

No abstract available

Publication types